|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0000894,
umls-concept:C0034693,
umls-concept:C0034721,
umls-concept:C0035412,
umls-concept:C0087111,
umls-concept:C0449243,
umls-concept:C0871261,
umls-concept:C1522449,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1979893,
umls-concept:C2911692
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2001-8-16
|
|
pubmed:abstractText |
In clinical practice a concomitant boost is usually given as a second daily dose to a reduced field. The question arises which part of treatment should be accelerated to achieve optimal tumor control. An experiment was performed on tumor bearing rats to determine the optimal timing of treatment acceleration for this experimental tumor system.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0179-7158
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
177
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
362-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11505622-Animals,
pubmed-meshheading:11505622-Cell Division,
pubmed-meshheading:11505622-Cell Survival,
pubmed-meshheading:11505622-Dose Fractionation,
pubmed-meshheading:11505622-Dose-Response Relationship, Radiation,
pubmed-meshheading:11505622-Male,
pubmed-meshheading:11505622-Neoplasm Transplantation,
pubmed-meshheading:11505622-Rats,
pubmed-meshheading:11505622-Rats, Inbred Strains,
pubmed-meshheading:11505622-Rhabdomyosarcoma,
pubmed-meshheading:11505622-Soft Tissue Neoplasms
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Impact of treatment acceleration and its timing on the response of the rhabdomyosarcoma R1H of the rat to fractionated irradiation.
|
|
pubmed:affiliation |
Abteilung für Strahlentherapie und Radioonkologie, Universität Hamburg, Germany. araabe@uke.uni-hamburg.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
